Chengrong Xie

Xiamen Translational Medical Key Laboratory Of Digestive System Tumor, Fujian Provincial Key Laboratory Of Chronic Liver Disease And Hepatocellular Carcinoma
Xiamen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Stabilization of FASN by USP5-mediated deubiquitination promotes hepatocellular carcinoma progression.

Stabilization of FASN by USP5-mediated deubiquitination promotes hepatocellular carcinoma progression.

Journal: Oncogenesis

Published: May 11, 2025

METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3.

METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3.

Journal: NPJ precision oncology

Published: January 16, 2025

Sophoricoside from sophora japonica L. is efficacious as monotherapy or in combination with lenvatinib in hepatocellular carcinoma via targeting EGFR.

Sophoricoside from sophora japonica L. is efficacious as monotherapy or in combination with lenvatinib in hepatocellular carcinoma via targeting EGFR.

Journal: Scientific reports

Published: December 18, 2024

TRIM55 restricts the progression of hepatocellular carcinoma through ubiquitin-proteasome-mediated degradation of NF90.

TRIM55 restricts the progression of hepatocellular carcinoma through ubiquitin-proteasome-mediated degradation of NF90.

Journal: Cell death discovery

Published: August 26, 2024

PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1.

PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1.

Journal: Cell death & disease

Published: July 19, 2024

The activation of the Notch signaling pathway by UBE2C promotes the proliferation and metastasis of hepatocellular carcinoma.

The activation of the Notch signaling pathway by UBE2C promotes the proliferation and metastasis of hepatocellular carcinoma.

Journal: Scientific reports

Published: January 26, 2024

Heat shock protein HSPA13 promotes hepatocellular carcinoma progression by stabilizing TANK.

Heat shock protein HSPA13 promotes hepatocellular carcinoma progression by stabilizing TANK.

Journal: Cell death discovery

Published: September 20, 2023

Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT-FOXO3 signalling pathway.

Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT-FOXO3 signalling pathway.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 31, 2023

Upregulation of helicase-like transcription factor predicts poor prognosis and facilitates hepatocellular carcinoma progression.

Upregulation of helicase-like transcription factor predicts poor prognosis and facilitates hepatocellular carcinoma progression.

Journal: Human cell

Published: December 25, 2022

Long non-coding RNA muskelin 1 antisense RNA as a potential therapeutic target in hepatocellular carcinoma treatment.

Long non-coding RNA muskelin 1 antisense RNA as a potential therapeutic target in hepatocellular carcinoma treatment.

Journal: Bioengineered

Published: May 17, 2022

RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31.

RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31.

Journal: Cell death discovery

Published: May 10, 2022

Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer.

Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 08, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026